Atherosclerosis in chronic kidney disease: more, less, or just different?

…, D Rodríguez-Puyol, J Pascual, C Barrios… - … , and vascular biology, 2019 - Am Heart Assoc
Patients with chronic kidney disease (CKD) are at an increased risk of premature mortality,
mainly from cardiovascular causes. The association between CKD on hemodialysis and …

Pharmacologic modulation of ACE2 expression

MJ Soler, C Barrios, R Oliva, D Batlle - Current hypertension reports, 2008 - Springer
Angiotensin-converting enzyme 2 (ACE2) is an enzymatically active homologue of
angiotensin-converting enzyme that degrades angiotensin I, angiotensin II, and other peptides. …

[HTML][HTML] Correlación entre el cociente proteína/creatinina en orina esporádica y las proteínas en orina de 24 horas

N Montero, MJ Soler, MJ Pascual, C Barrios… - Nefrología …, 2012 - SciELO Espana
Introducción: Las proteínas presentan una eliminación variable a lo largo del día; por ello
clásicamente se ha considerado la proteinuria de 24 horas como el método de referencia …

Treatment for hepatitis C virus‐associated mixed cryoglobulinaemia

…, A Favà, E Rodriguez, C Barrios… - Cochrane Database …, 2018 - cochranelibrary.com
Background Hepatitis C virus (HCV)‐associated mixed cryoglobulinaemia is the manifestation
of an inflammation of small and medium‐sized vessels produced by a pathogenic IgM …

Targeting the degradation of angiotensin II with recombinant angiotensin-converting enzyme 2: prevention of angiotensin II–dependent hypertension

…, E Rodriguez, FR González-Pacheco, C Barrios… - …, 2010 - Am Heart Assoc
Angiotensin (Ang)-converting enzyme 2 (ACE2) cleaves Ang II to form Ang-(1-7). Here we
examined whether soluble human recombinant ACE2 (rACE2) can efficiently lower Ang II and …

[HTML][HTML] Factores predictivos de nefropatía no diabética en pacientes diabéticos. Utilidad de la biopsia renal

S Bermejo, MJ Soler, J Gimeno, C Barrios, E Rodríguez… - nefrologia, 2016 - Elsevier
Antecedentes y objetivos La afectación renal del diabético solo puede determinarse mediante
biopsia renal, que presenta una elevada prevalencia de lesiones no diabéticas. Los …

[PDF][PDF] Association of systemic lupus erythematosus with decreased immunosuppressive potential of the IgG glycome

…, I Trbojević‐Akmačić, C Barrios… - Arthritis & …, 2015 - Wiley Online Library
Objective Glycans attached to the Fc portion of IgG are important modulators of IgG effector
functions. Interindividual differences in IgG glycome composition are large and they …

[HTML][HTML] Gut-microbiota-metabolite axis in early renal function decline

C Barrios, M Beaumont, T Pallister, J Villar… - PloS one, 2015 - journals.plos.org
Introduction Several circulating metabolites derived from bacterial protein fermentation have
been found to be inversely associated with renal function but the timing and disease …

A metabolome-wide association study of kidney function and disease in the general population

P Sekula, ON Goek, L Quaye, C Barrios… - Journal of the …, 2016 - journals.lww.com
Small molecules are extensively metabolized and cleared by the kidney. Changes in serum
metabolite concentrations may result from impaired kidney function and can be used to …

Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial

…, J Barbic, D Barisic, JC de Jesus Barreto, C Barrios… - The Lancet, 2023 - thelancet.com
Background Sparsentan, a novel, non-immunosuppressive, single-molecule, dual endothelin
angiotensin receptor antagonist, significantly reduced proteinuria versus irbesartan, an …